Glutaryl-Phe-pNA is a peptide-related substrate composed of a glutaryl acyl group linked to phenylalanine and a p-nitroanilide (pNA) leaving group, placing it in the class of chromogenic peptide substrates used for aminopeptidase- and protease-related assays. The molecule bears an amide-linked glutaryl moiety and a terminal anilide, with the phenylalanine side chain presenting a hydrophobic benzyl group and the pNA group providing a chromophore that can be released upon cleavage of the peptide bond. In biochemical and analytical workflows, it is employed as a synthetic, defined substrate for monitoring proteolytic activity by tracking the formation of the p-nitroaniline chromophore under controlled conditions.
Glutaryl-Phe-pNA is a glutaryl-activated phenylalanine p-nitroanilide derivative designed for amide-based recognition and enzymatic readouts. The structure combines a glutaryl moiety with a stereodefined L-phenylalanine residue and a terminal p-nitroanilide chromophore, enabling strong electronic coupling between the amide hydrolysis event and the aniline reporter. The molecule bears an amide linkage that can participate in acyl-enzyme formation and subsequent cleavage, while the aromatic side chain supports substrate mimicry for protease active sites that accommodate phenylalanine. The resulting product is a research-grade biochemical reagent and analytical intermediate that can be used to probe proteolytic specificity and to generate downstream labeled or derivatized substrate analogs.
1. Protease Activity Assays
Glutaryl-Phe-pNA is applied in protease activity screening and kinetic characterization within chemical biology and enzymology workflows. The glutaryl acyl group and the phenylalanine side chain create a substrate pattern that can be recognized by proteases with acyl-binding preferences, while the p-nitroanilide reporter enables conversion of cleavage into a measurable chromogenic signal. The amide architecture supports controlled enzymatic hydrolysis, and the stereochemistry at the amino acid center can influence binding orientation in chiral active sites. Glutaryl-Phe-pNA can be employed as a substrate in assay development for mechanistic studies, inhibitor profiling, and comparative specificity mapping across protease families.
2. Peptide Substrate Design
Glutaryl-Phe-pNA is suitable for peptide substrate and peptidomimetic construction in substrate engineering and molecular recognition research. The compound's glutaryl-phenylalanine motif functions as a compact acyl-amino acid unit that can be extended into longer peptide-like sequences or used as a modular fragment for analog libraries. The p-nitroanilide end group provides a convenient reporter handle that can be retained or replaced during derivatization to tune detection wavelength or cleavage position. Glutaryl-Phe-pNA can therefore serve as a reference substrate when designing C-terminal and side-chain variants for structure-activity relationship studies in protease selectivity and substrate accommodation.
3. Analytical Research Standards
Glutaryl-Phe-pNA is used in analytical research as a chromogenic substrate standard for method qualification and calibration in biochemical assay platforms. The stable amide linkage and the conjugated p-nitroanilide chromophore provide a reproducible signal response upon enzymatic cleavage, supporting consistent readout in spectrophotometric or plate-based formats. The presence of the glutaryl group helps maintain a defined acyl environment, which can be important when comparing assay conditions across instruments or reagent lots. Glutaryl-Phe-pNA can also be applied as an analytical intermediate to generate related p-nitroanilide substrates used for specificity panels and routine monitoring of protease activity.
4. Enzyme Inhibitor Profiling
Glutaryl-Phe-pNA is applied in inhibitor screening and mechanistic evaluation of enzyme active-site ligands in biochemical research settings. The substrate's glutaryl acyl group and phenylalanine residue can participate in the same binding interactions that inhibitors compete for, while the p-nitroanilide reporter translates inhibition into a measurable change in cleavage rate. The chiral amino acid center supports realistic substrate geometry for enzymes that discriminate between stereoisomers, improving interpretability of structure-function relationships. Glutaryl-Phe-pNA can be utilized to support SAR studies of small molecules or peptide-like inhibitors by providing a consistent cleavage-based endpoint for comparative analysis.
5. Process Chemistry Intermediate
Glutaryl-Phe-pNA is relevant to process chemistry and fine chemical synthesis as a protected/activated amino acid derivative class reagent that can be scaled or adapted for downstream substrate manufacturing. The molecule's defined acyl-amide connectivity and chromophore-bearing terminal group make it a practical intermediate for producing families of glutaryl- and amino acid-based p-nitroanilide substrates with systematic side-chain variation. The functional group set supports controlled synthetic planning, including acylation and amide-forming strategies that preserve the stereochemical integrity of the phenylalanine residue. Glutaryl-Phe-pNA can therefore serve as a reference compound in industrial intermediate preparation and as a template for developing assay reagent portfolios used in biochemical testing and industrial bioprocess monitoring.
1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
2. Myotropic activity of allatostatins in tenebrionid beetles
3. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More